UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Migraine

Key Points

• The analysis aims to evaluate the effectiveness of cannabis-based medicinal products (CBMPs) for treating migraines.
• Conducted analysis within the UK Medical Cannabis Registry
• Evaluated clinical outcomes related to migraine treatment
• Assessed current findings against the need for randomized controlled trials
• There is a reported utility of CBMPs in managing migraines
• A call for randomized controlled trials to establish a direct causative relationship

Abstract